[Temporary Announcement] Puang Medical: Announcement of Resolutions of the 19th Meeting of the Second Board of Directors
Securities code: 920069 Securities abbreviation: Puang Medical Announcement number: 2026-110
Puang (Hangzhou) Medical Technology Co., Ltd.
Announcement of Resolutions of the 19th Meeting of the Second Board of Directors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
1. Meeting convening and attendance
(1) Meeting status
Meeting time: August 25, 2026
Meeting location: Conference Room 1, Puang Medical Company
3.Meeting method: on-site combined with communication voting
Time and method of issuing board meeting notice: by communication on August 20, 2026 5. Meeting host: Chairman Hu Chaoyu
Meeting attendees: all senior managers
Explanation on the legality and compliance of the convening situation:
The convening, holding and resolution review procedures of this meeting complied with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association.
(2) Meeting attendance
The meeting should be attended by 9 directors, and 9 directors should be present and authorized to attend.
Directors Lu Yan, Xie Shilei, Zhou Huali and Qiu Juanping participated in the voting by communication due to work arrangements.
2. Proposal review status
(1) Consideration and approval of the “Proposal on the 2026 Semi-annual Report and its Summary” 1. Contents of the proposal:
In accordance with relevant regulations such as the "Beijing Stock Exchange Stock Listing Rules", "Beijing Stock Exchange Listed Companies Business Handling Guide No. 6 - Periodic Reporting Related Matters" and the "Articles of Association", combined with the company's operating conditions and financial status from January to June 2026, the company prepared the "2026 Semi-Annual Report" and the "2026 Semi-Annual Report Summary".
For details, please refer to the "2026 Semi-Annual Report" (Announcement No.: 2026-111) and "2026 Semi-Annual Report Summary" (Announcement No.: 2026-112) disclosed by the company on the official information disclosure platform of the Beijing Stock Exchange (www.bse.cn) on the same day.
- The voting results of the motion: 9 votes in favor; 0 votes against; 0 abstentions.
This proposal has been reviewed and approved at the sixth meeting of the Audit Committee of the second board of directors in 2026, and it was agreed to submit the proposal to the board of directors for consideration.
- Avoidance of voting:
This proposal does not involve related transactions and there is no need to avoid voting.
- Submit the voting status of the shareholders’ meeting:
This proposal does not need to be submitted to the shareholders' meeting for review.
(2) Consider and approve the "Proposal on the Special Report on the Deposit, Management and Actual Use of Funds Raised in the Half-Year of 2026"
- Contents of the motion:
In accordance with relevant regulations such as the "Company Law of the People's Republic of China", the Securities Law of the People's Republic of China, the Beijing Stock Exchange Stock Listing Rules and the "Beijing Stock Exchange Guidelines for the Continuous Supervision of Listed Companies No. 9 - Management of Raised Funds", as well as the relevant requirements of the "Raised Funds Management System" formulated by the company, the company prepared the "Special Report on the Deposit, Management and Actual Use of Raised Funds for the Half Year of 2026".
For details, please refer to the "Special Report on the Deposit, Management and Actual Use of Funds Raised in the Half-Year 2026" disclosed by the company on the Beijing Stock Exchange Information Disclosure Platform (www.bse.cn) on the same day (Announcement No.: 2026-113).
- The voting results of the motion: 9 votes in favor; 0 votes against; 0 abstentions.
This proposal has been reviewed and approved at the sixth meeting of the Audit Committee of the second board of directors in 2026, and it was agreed to submit the proposal to the board of directors for consideration.
- Avoidance of voting:
This proposal does not involve related transactions and there is no need to avoid voting.
- Submit the voting status of the shareholders’ meeting:
This proposal does not need to be submitted to the shareholders' meeting for review.
(3) Consider and approve the "Proposal on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration"
- Contents of the motion:
The exercise conditions for the first exercise period of the company's 2024 stock option incentive plan have been met, and the number of exercisable shares is 5,828. The exercise of related stock options has been completed, and the stock option exercise matters were completed at China Securities Depository and Clearing Co., Ltd. on August 6, 2026. The company's total share capital was changed from 52,914,000 shares to 52,919,828 shares, and the registered capital was RMB The amount of RMB 52,914,000 was changed to RMB 52,919,828, and the relevant provisions of the Articles of Association are planned to be revised accordingly.
For details, please refer to the "Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration" (Announcement No.: 2026-114) disclosed by the company on the Beijing Stock Exchange Information Disclosure Platform (www.bse.cn) on the same day.
The voting results of the motion: 9 votes in favor; 0 votes against; 0 abstentions.
Avoidance of voting:
This proposal does not involve related party transactions and there is no need to avoid voting.
- Submit the voting status of the shareholders’ meeting:
This proposal still needs to be submitted to the shareholders' meeting for review.
(4) Consideration and approval of the "Proposal on Proposing to Convene the Second Extraordinary Shareholders' Meeting in 2026"
- Contents of the motion:
The board of directors proposed to convene the second extraordinary shareholders' meeting of Puang (Hangzhou) Medical Technology Co., Ltd. in 2026 on September 15, 2026.
For details, please refer to the "Announcement on the Convening of the Second Extraordinary Shareholders' Meeting in 2026 (Online Voting Provided)" disclosed by the company on the Beijing Stock Exchange Information Disclosure Platform (www.bse.cn) on the same day (announcement number: 2026-115).
The voting results of the motion: 9 votes in favor; 0 votes against; 0 abstentions.
Avoidance of voting:
This proposal does not involve related party transactions and there is no need to avoid voting.
- Submit the voting status of the shareholders’ meeting:
This proposal does not need to be submitted to the shareholders' meeting for review.
3. Documents for reference
(1) "Resolution of the 19th Meeting of the Second Board of Directors of Puang (Hangzhou) Medical Technology Co., Ltd."
(2) "Resolution of the Sixth Meeting of the Audit Committee of the Second Board of Directors of Puang (Hangzhou) Medical Technology Co., Ltd. in 2026"
Board of Directors of Puang (Hangzhou) Medical Technology Co., Ltd.
August 26, 2026